Ligand Pharmaceuticals | Spese Operative



Operating Expenses Cambiamento Data
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 161.51M 2.4M 2025-03
Baxter International USD 3.19B 644M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Insmed USD 340.96M 6.11M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Ligand Pharmaceuticals USD 81.55M 29.1M 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.66B 1.67B 2025-03
Pacira USD 166.93M 4.38M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Veracyte USD 114.46M 10.61M 2024-12



Ligand Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.